Pure Global

Bilirubin Direct Test Kit - India CDSCO Medical Device Registration

Bilirubin Direct Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000069_c2a935c5717ed837a139e924f4e8c1c8_ab4deb3667ce5b347b8386ed491e08c6. This device is marketed under the brand name Piiko Haematology Assay Kit. The license holder is Tangentup Labs Private Limited, and it is classified as Device Class Class B. The approving authority is Kerala.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Bilirubin Direct Test Kit
UID: MFG/IVD/2022/000069_c2a935c5717ed837a139e924f4e8c1c8_ab4deb3667ce5b347b8386ed491e08c6

Brand Name

Piiko Haematology Assay Kit

Device Class

Class B

Approving Authority

Kerala

Product Information

The Piiko Bilirubin Direct Test Kit is used for the estimation of direct bilirubin in blood serum. The blood serum sample is fed into the reader machine in a centrifuge vial and the device pipettes out the required serum sample and is then fed into the Piiko Bilirubin Direct Test Kit for mixing and further processing. The reader machine will then carry out estimation using specialised colorimetry module in the reader machine

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing